Showing results (371-380 of 453) with videos related to
Sort By:
Pageof 46
Radiology. Imaging Cancer|January 28, 2022
The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1Hsiaoju S Lee, Sally W Schwarz, Erin K Schubert, et al.Bioorganic & Medicinal Chemistry Letters|September 4, 2012
Synthesis, radiolabeling and initial in vivo evaluation of [(11)C]KSM-01 for imaging PPAR-α receptorsKiran Kumar Solingapuram Sai, Kun-Eek Kil, Zhude Tu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2023
Molecular Imaging of Pulmonary Inflammation in Users of Electronic and Combustible Cigarettes: A Pilot StudyReagan R Wetherill, Robert K Doot, Anthony J Young, et al.ACS Chemical Neuroscience|December 22, 2012
Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compoundsRobert R Luedtke, Yogesh Mishra, Qi Wang, et al.Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Brain-gut axis imaging, motion correction with [ 11 C]-carfentanil total-body PETElizabeth J Li, Sophie Lammers, Chia-Ju Hsieh, et al.European Journal of Medicinal Chemistry|October 13, 2020
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ2R/TMEM97 ligandsXiao-Yang Xie, Yu-Yun Li, Wen-Hui Ma, et al.Neurosurgery|February 10, 2007
In vivo imaging in a murine model of glioblastomaSarah C Jost, John E Wanebo, Sheng-Kwei Song, et al.Synapse (New York, N.Y.)|December 1, 1996
Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomographyR H Mach, M A Nader, R L Ehrenkaufer, et al.Nuclear Medicine and Biology|August 1, 1993
The use of [18F]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: model alkylation studies and its application in the design of dopamine D1 and D2 receptor-based imaging agentsR H Mach, S T Elder, T E Morton, et al.Molecular Cancer|March 8, 2014
Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancerGunjal Garg, Suwanna Vangveravong, Chenbo Zeng, et al.Pageof 46